These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 4082632
1. The metabolism of N-hydroxyphenacetin in vitro and in vivo. Fischbach T, Lenk W. Xenobiotica; 1985 Nov; 15(11):915-27. PubMed ID: 4082632 [Abstract] [Full Text] [Related]
2. Species-specific activation of phenacetin into bacterial mutagens by hamster liver enzymes and identification of N-hydroxyphenacetin O-glucuronide as a promutagen in the urine. Camus AM, Friesen M, Croisy A, Bartsch H. Cancer Res; 1982 Aug; 42(8):3201-8. PubMed ID: 7046920 [Abstract] [Full Text] [Related]
3. N-hydroxyphenacetin, a new urinary metabolite of phenacetin in the rat. McLean S, Davies NW, Watson H, Favretto WA, Bignall JC. Drug Metab Dispos; 1981 Aug; 9(3):255-60. PubMed ID: 6113936 [Abstract] [Full Text] [Related]
4. Formation of reactive metabolites of phenacetin in humans and rats. Veronese ME, McLean S, D'Souza CA, Davies NW. Xenobiotica; 1985 Nov; 15(11):929-40. PubMed ID: 4082633 [Abstract] [Full Text] [Related]
5. Activation of N-hydroxyphenacetin to mutagenic and nucleic acid-binding metabolites by acyltransfer, deacylation, and sulfate conjugation. Vaught JB, McGarvey PB, Lee MS, Garner CD, Wang CY, Linsmaier-Bednar EM, King CM. Cancer Res; 1981 Sep; 41(9 Pt 1):3424-9. PubMed ID: 7020926 [Abstract] [Full Text] [Related]
6. Metabolic activation and genotoxicity of N-hydroxy-2-acetylaminofluorene and N-hydroxyphenacetin derivatives in Reuber (H4-II-E) hepatoma cells. Glowinski IB, Sanderson ND, Hayashi S, Thorgeirsson SS. Cancer Res; 1984 Mar; 44(3):1098-104. PubMed ID: 6692396 [Abstract] [Full Text] [Related]
7. Metabolism of phenacetin and N-hydroxyphenacetin in isolated rat hepatocytes. McLean S. Naunyn Schmiedebergs Arch Pharmacol; 1978 Nov; 305(2):173-80. PubMed ID: 732893 [Abstract] [Full Text] [Related]
8. Additional routes in the metabolism of phenacetin. Fischbach T, Lenk W. Xenobiotica; 1985 Feb; 15(2):149-64. PubMed ID: 4002737 [Abstract] [Full Text] [Related]
9. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA. Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [Abstract] [Full Text] [Related]
10. Mechanism of N-hydroxyacetylarylamine mutagenicity in the Salmonella test system: metabolic activation of N-hydroxyphenacetin by liver and kidney fractions from rat, mouse, hamster, and man. Wirth PJ, Dybing E, von Bahr C, Thorgeirsson SS. Mol Pharmacol; 1980 Jul; 18(1):117-27. PubMed ID: 6997726 [No Abstract] [Full Text] [Related]
17. Kinetics of metabolite formation and elimination in the perfused rat liver preparation: differences between the elimination of preformed acetaminophen and acetaminophen formed from phenacetin. Pang KS, Gillette JR. J Pharmacol Exp Ther; 1978 Oct; 207(1):178-94. PubMed ID: 702339 [Abstract] [Full Text] [Related]
18. Reaction of mutagenic phenacetin metabolites with glutathione and DNA. Possible implications for toxicity. Mulder GJ, Kadlubar FF, Mays JB, Hinson JA. Mol Pharmacol; 1984 Sep; 26(2):342-7. PubMed ID: 6482879 [Abstract] [Full Text] [Related]
20. Role of the hepatic artery in the metabolism of phenacetin and acetaminophen: intravital microscopic and multiple-indicator dilution study in perfused rat liver. Pang KS, Sherman IA, Schwab AJ, Geng W, Barker F, Dlugosz JA, Cuerrier G, Goresky CA. Hepatology; 1994 Sep; 20(3):672-83. PubMed ID: 8076925 [Abstract] [Full Text] [Related] Page: [Next] [New Search]